Correlation Between Neurocrine Biosciences and Uber Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Uber Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Uber Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Uber Technologies, you can compare the effects of market volatilities on Neurocrine Biosciences and Uber Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Uber Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Uber Technologies.

Diversification Opportunities for Neurocrine Biosciences and Uber Technologies

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Neurocrine and Uber is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Uber Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uber Technologies and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Uber Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uber Technologies has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Uber Technologies go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Uber Technologies

Assuming the 90 days trading horizon Neurocrine Biosciences is expected to generate 0.66 times more return on investment than Uber Technologies. However, Neurocrine Biosciences is 1.52 times less risky than Uber Technologies. It trades about 0.1 of its potential returns per unit of risk. Uber Technologies is currently generating about 0.06 per unit of risk. If you would invest  3,483  in Neurocrine Biosciences on September 4, 2024 and sell it today you would earn a total of  381.00  from holding Neurocrine Biosciences or generate 10.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  Uber Technologies

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Neurocrine Biosciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Uber Technologies 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Uber Technologies are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Uber Technologies may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Neurocrine Biosciences and Uber Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and Uber Technologies

The main advantage of trading using opposite Neurocrine Biosciences and Uber Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Uber Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uber Technologies will offset losses from the drop in Uber Technologies' long position.
The idea behind Neurocrine Biosciences and Uber Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios